Navigation Links
Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Date:10/2/2007

San Antonio Researcher, Educator Brings Expertise to Organization's Focus

on Breast Cancer Disparities

DALLAS, Oct. 2 /PRNewswire/ -- Susan G. Komen for the Cure, the global leader in the breast cancer movement, has appointed Amelie G. Ramirez, DrPH, of San Antonio, to its Scientific Advisory Board.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO )

Ramirez joins a group of five other leading breast cancer researchers and clinicians who comprise Komen's Scientific Advisory Board. The group's leader is Dr. Eric P. Winer, internationally known medical oncologist, researcher and educator from the Dana-Farber Cancer Institute and Harvard Medical Center, who is Komen's chief scientific advisor. Komen's Scientific Advisory Board lends insight and guidance to Komen in its grantmaking and health education initiatives. Komen's Scientific Advisory Board members also provide expert perspective and commentary on breaking news and emerging developments in breast cancer research and treatment.

Ramirez, who also serves as chairman of Komen's National Hispanic/Latino Advisory Council, is a professor of epidemiology and biostatistics at the University of Texas Health Science Center at San Antonio (UTHSCSA), where she also is founding director of the Institute for Health Promotion Research. In 2006, Dr. Ramirez received two endowments to support her research and that of the Institute. At UTHSCSA, she was named the Dielmann Chair in Health Disparities Research and Community Outreach. At the Cancer Therapy and Research Center (CTRC) in San Antonio, Dr. Ramirez was given the Max and Minnie Tomerlin Voelcker Endowed Chair in Cancer Healthcare Disparities and Outreach. Dr. Ramirez is director of outreach and health disparities at the CTRC.

Over the past 25 years, she has directed numerous state-, federal- and privately funded research programs focusing on human and organizational communication to reduce chronic disease and cancer health disparities affecting Hispanics/Latinos and other populations. She has authored numerous peer-reviewed articles and is frequently invited to speak at scientific meetings.

Ramirez is a former member of the National Cancer Advisory Board and the National Heart, Lung, and Blood Advisory Council of the National Institutes of Health.

"Dr. Ramirez's unique expertise and keen insight has proven invaluable to Komen identifying and addressing breast health disparities among specific population groups, including Hispanic and Latino people. As a member of its Scientific Advisory Board (SAB), Dr. Ramirez will be instrumental in Komen's ability to reach even more deeply into areas of our society that remain medically underserved," said Dr. Winer.

In addition to Dr. Winer and Dr. Ramirez, the SAB includes the following physicians and researchers:

-- Melissa L. Bondy, Ph.D., professor of epidemiology at the University of

Texas M.D. Anderson Cancer Center, Houston, and director of the

Childhood Cancer Epidemiology and Prevention Center, a collaborative

program between M.D. Anderson Cancer Center, Baylor College of Medicine

and Texas Children's Hospital.

-- Powel Brown, professor of medicine, Baylor College of Medicine;

associate director of cancer prevention and director of cancer

prevention and populations studies program, Dan L. Duncan Cancer

Center; and associate director of research at the Breast Care Center

Baylor-Methodist.

-- H. Kim Lyerly, M.D., George Barth Geller Professor of Research at Duke

University, Durham, N.C.; director of the Duke Comprehensive Cancer

Center and principal investigator of the Duke Specialized Program in

Research Excellence (SPORE).

-- George W. Sledge, M.D., Ballve-Lantero Professor of Oncology and

co-director of the breast cancer program at the Indiana University

Cancer Center. He is also professor of medicine and pathology at

Indiana University School of Medicine. Dr. Sledge was awarded the Komen

Brinker Award of Scientific Distinction in 2006.

-- Sara Sukumar, Ph.D., professor of oncology and pathology and co-

director of the breast cancer research program at the Sidney Kimmel

Cancer Center at Johns Hopkins University School of Medicine in

Baltimore.

About Susan G. Komen for the Cure

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure, we have invested nearly $1 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit http://www.komen.org or call 1-800 I'M AWARE.


'/>"/>
SOURCE Susan G. Komen for the Cure
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Scientific markers of aging described
2. A Settlement Over Stem Cell Controversy Through Scientific Research
3. A Scientific Explanation For Out Of Body Experience
4. PUFA Good For Heart: Gets The Scientific Seal
5. Forensic Phonetics – Scientific Solution for Legal Problem
6. Old Indian Advice Has A Scientific Backing Now!
7. India To Highlight Its Scientific Achievements
8. Thumbs up in weight loss for vegetarian diets: scientific review
9. Scientific Research in a War Zone
10. Unscientific Depression Drugs aplenty in Health Stores
11. No Scientific Evidence to Support Drug Safety Recommendations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... ... Media, the industry leader in digital marketing for medical practices, has been recognized as one ... the Inc. 5000 for the second time in two years. Shawn Miele, Chief Executive Officer ... for the second year in a row. It’s extremely difficult to make this list once. ...
(Date:8/17/2017)... Yorba Linda, Ca (PRWEB) , ... August 17, 2017 , ... ... by the FDA to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. ... their 21 CFR Part 11 ruling. , Presented as part of the ...
(Date:8/16/2017)... Kalamazoo, Michigan (PRWEB) , ... August 16, 2017 , ... ... Applications are now being accepted. , Students who successfully complete the seven-week long ... a Certified Nurse Assistant (CNA). The average starting salary for a CNA in Kalamazoo ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... Greenfield Advisors ... companies in the U.S. for the second year in a row. The Inc. 5000 ... past three years. , “To be on the list once is a great accomplishment, ...
(Date:8/16/2017)... , ... August 16, 2017 , ... Any Lab ... 5000. The company ranked #4429 on the newly released, 36th annual Inc. 5000 ... a unique look at the most successful companies within the American economy’s most dynamic ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO ... as president, effective Aug. 7, 2017. ... pursue other interests and will serve as president emeritus during ... served us in multiple leadership roles since he joined Diplomat ... and has provided decisive, strategic leadership which continues to benefit ...
(Date:8/4/2017)... CINCINNATI , Aug. 3, 2017  Agragen, ... science company active in the biopharmaceutical, nutraceutical, and ... its development of its lead drug candidates, AGR131.  ... a proinflammatory cytokine from the blood of patients ... psoriasis, and inflammatory bowel disease. ...
(Date:8/2/2017)... 2017  Life Flight Network and PeaceHealth Oregon Network announced ... care and operational efficiency for patients at hospitals in ... Cottage Grove , and Florence, Oregon ... Life Flight Network work collaboratively to move patients who require ... a time sensitive emergency exists. ...
Breaking Medicine Technology: